Fig. 1 · Structure
Documents & Downloads
BMS-593214
FVIIa Inhibitor
BMS-593214 is a selective inhibitor of factor VIIa (FVIIa) that acts primarily through direct competitive inhibition at the enzyme's active site. This compound exhibits significant antithrombotic and antihemostatic properties, effectively hindering FVIIa-mediated coagulation pathways. BMS-593214 has been shown to prevent electro-induced carotid artery thrombosis as well as wire-induced vena cava thrombosis, making it a valuable tool for research in thrombotic disorders and coagulation mechanisms.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 1004551-40-9 |
| Applications | FVIIa Inhibitor |
| Formula | C31H27N3O4 |
| Molecular Weight | 505.56 |
| SMILES | O=C(O)C1=CC=C(C=C1)C2=CC(O)=C(C=C2[C@@H]3NC4=C([C@@]5([C@]3(CC6=C5C=CC=C6)[H])[H])C=C(C=C4)C(N)=N)OC |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.